This Means War: Identical Labels Recommended For Gilead, AbbVie's HCV Drugs In Europe

 
• By Lucie Ellis-Taitt

AbbVie and Gilead have won positive recommendations in Europe and matching eight-week dosing labels for their latest hepatitis C combination therapies, Maviret and Vosevi – now it's all about the price.

Hepatitis C virus
Gilead Manages To Match AbbVie's Hep C Label In Europe Despite Trial Miss

More from New Products

More from Scrip